Merck, known as MSD outside of the United States and Canada, announced the initiation of the company’s Phase 3 clinical program, CORALreef, for MK-0616,...
Kerecis® Shield™, the new fish-skin wound-treatment product family for private doctors’ clinics, has been approved by multiple leading Medicare Administrative Contractors (MACs). This means that...
Biobot Analytics, a global leader in wastewater intelligence, announced that it is launching a Respiratory Illnesses Panel that will include concurrent wastewater monitoring for...
The U.S. Food and Drug Administration approved Tyruko, the first biosimilar to Tysabri (natalizumab) injection for the treatment of adults with relapsing forms of...
Nectero Medical, a clinical-stage biotechnology company pioneering novel therapies to treat aneurysmal disease, announced that the U.S. Food and Drug Administration (FDA) has granted...
